-
Entity
-
Individual
-
Location
-
C/O Avalanche Biotechnologies, Inc., 1035 O'brien Drive, Suite A, Menlo Park, CA
-
Summary
-
The estimated net worth of Hans Hull is at least $2.86M dollars as of July 12, 2024. Hans Hull is the Chief Business Officer of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $2.86M.